Bone Marrow Infusion for Blood Cancer Patients in Critical Care
Part of Blood & lymphatic clinical trials.
This trial studies a way to give fluids and medicines directly into the bone marrow (intraosseous infusion) for people with serious blood diseases who are in critical condition. It may help when regular IV access is difficult or urgent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a serious blood disease, such as a fast-growing blood cancer, severe infection, low blood counts, or organ failure.
- You must be in critical condition and need close monitoring or life support.
- You must not have a fracture, infection, or major surgery at the planned injection site.
- You must not have had a bone marrow infusion at the same site in the last 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the bone marrow behaves in people with sepsis and other critical illnesses. It aims to see if changes in bone marrow are linked to how sick a patient is and their chance of recovery. Participants will have a small sample of bone marrow taken from the pelvis.
This trial tests a specific type of bone marrow transplant for people with sickle cell disease (or certain other blood disorders) who have had serious complications despite standard care. It aims to see if removing the patient’s immune cells and using a matched donor’s cells can improve outcomes and reduce complications.
This trial tests whether infusing stem cells from umbilical cord blood can help your bone marrow recover and make healthy blood cells again after chemotherapy. The goal is to improve your blood counts and reduce the need for transfusions.
This trial studies how bone marrow and blood-making cells may behave after severe trauma or after elective (planned) hip surgery. It may help researchers understand why recovery can be harder in some people and guide better care.
This trial tests whether giving iron through an IV can help prevent or treat low red blood cell counts (anemia) in people with ovarian cancer. The goal is to reduce the need for blood transfusions and improve quality of life during treatment.
This trial tests whether injecting your own bone marrow into the hip can help heal early-stage osteonecrosis (bone death) before the bone collapses. It is for people who have not had prior hip surgery and do not have certain conditions like sickle cell disease.
Hear when a new Intraosseous Infusions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.